Marvell's Google Bet: A $120 Billion Question Hangs Over Next Week's Earnings

Marvell's Google warrant ties $12.2B equity upside to TPU chip revenue tranches, sparking bull-bear debate on growth vs. dilution.

When Marvell Technology handed Google a warrant on Wednesday, it did more than just tee up its own quarterly report. It handed the market a puzzle: how much of a theoretical $120 billion revenue opportunity can actually be converted into billable business — and how quickly?

The warrant entitles Alphabet to acquire up to 58.97 million Marvell shares at $206.58 apiece, a transaction worth roughly $12.2 billion if exercised in full. But the terms are anything but straightforward. Only 1.36 million shares vest in the first year; the remainder unlocks in 240 tranches of $500 million in revenue each, staggered through the end of fiscal 2033. In other words, Google's equity upside is directly tied to how much custom silicon Marvell actually ships for the TPU ecosystem — AI inference accelerators, memory controllers, and networking interface chips alike.

The market's initial reaction was swift. Marvell shares jumped double digits on Wednesday, briefly rising more than 10 percent, while rival Broadcom slipped. The stock now trades at €203.75, just below its 50-day moving average of €204.67 — a sign that the initial euphoria has already been partially digested. Yet the equity remains roughly 30 percent below its 52-week high of $290.35, reached in early June, underscoring just how volatile the name has been. Even after the recent surge, the stock is up 176 percent year-to-date, carried by relentless demand for AI infrastructure.

The Bull Case: A Multi-Year Growth Backbone

For optimists, the Google warrant represents something Marvell has long lacked: visibility. If the company hits the agreed-upon revenue tranches, it secures a predictable, multi-year growth trajectory that extends well beyond its core data center chip business — which already grew 27 percent year-over-year to $1.83 billion in the first quarter of the current fiscal year.

Barclays reaffirmed its Overweight rating with a $275 price target on Wednesday, modeling an additional $18.5 billion in annual revenue and earnings per share of $6.15 at a 35 percent operating margin, assuming the tranches are achieved. RBC is even more aggressive, with a $360 target. The broader Street consensus shows 38 of 43 analysts at Buy or Strong Buy.

RBC's Srini Pajjuri views the 8-K filing as the first official validation of Marvell's role in the hyperscaler custom-silicon business. And if Google expands its TPU ecosystem as expected — from roughly $3 billion in revenue in 2026 to $25 billion in 2027 — Marvell stands to benefit disproportionately as a second source, without becoming wholly dependent on a single customer.

The Bear Case: Dilution, Backend-Loading, and a Dominant Rival

The flip side is equally clear. The warrant represents roughly 7 percent dilution of outstanding shares, with not a single dollar of incremental revenue yet booked. Barclays itself flags the risk of "backend-loading" — the tranches could be heavily concentrated in the later years through 2033, and in a worst-case scenario, never fully exercised. The SEC filing contains neither product details nor a concrete timeline.

Morningstar's William Kerwin offers a more measured read: this is a "growing pie," not a displacement of Broadcom, which reportedly still controls over 70 percent of the custom AI chip market and is expected to handle the bulk of Google's TPU volume — estimated at $80 billion to $90 billion for the coming year. That leaves Marvell potentially relegated to a supporting role if Google doesn't diversify its orders as hoped.

Valuation adds another layer of risk. Marvell trades at roughly 53 times expected earnings and 16.5 times sales — ambitious multiples that leave little room for disappointment. Insider sales of more than $632 million over the past three months are a signal investors shouldn't ignore, and the annualized 30-day volatility of 91 percent speaks to how jittery the market remains.

Analyst Divergence and a Possible Regulatory Tailwind

The warrant announcement triggered a flurry of target adjustments, though the direction was hardly uniform. TD Cowen raised its target from $200 to $225 on Tuesday, keeping a Hold rating and citing Marvell's leadership in optical DSP solutions for AI data centers. Goldman Sachs lifted its target from $180 to $195 on Monday, maintaining a neutral stance while acknowledging the company's strong positioning in custom silicon. UBS, by contrast, cut its target from $340 to $300 but kept a Buy rating, pointing to sustained demand for optical networking technology. Morgan Stanley, with a $195 target and Equal Weight rating, flagged a potential additional opportunity: a chip codenamed "Frozen v2" for Google that could offer further upside in the custom silicon business.

A separate regulatory development could provide additional tailwinds. Reports suggest the FCC is considering a ban on new optical transceivers manufactured in China. If implemented, demand would likely shift toward non-Chinese suppliers like Marvell.

India Expansion and the Road Ahead

Separately, Marvell announced plans to invest $250 million over the next three years to expand its research and development sites in Bangalore and Hyderabad. The workforce there is expected to double, making India the company's second-largest R&D hub.

Two dates now loom large for investors. On August 27, Marvell reports second-quarter fiscal 2027 results, including a revenue forecast of $2.7 billion for the current quarter. On October 6, the company hosts an investor day. Both events will test whether the Google story can be backed by hard numbers — or whether the market's enthusiasm has once again run ahead of the fundamentals. Until then, the stock sits between support and resistance, with investors watching closely to see whether management can turn a $120 billion theoretical ceiling into a credible, tranche-by-tranche reality.